R 1456Alternative Names: R1456
Latest Information Update: 05 Jul 2006
At a glance
- Originator Roche
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Emphysema
Most Recent Events
- 05 Jul 2006 No development reported - Preclinical for Emphysema in Europe (unspecified route)
- 11 Apr 2002 Preclinical trials in Emphysema in Europe (unspecified route)